PG
NKE icon

Prostatis Group’s Nike NKE Stock Holding History

Prostatis Group’s Portfolio NKE Stock Details NKE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,590
Closed -$1.16M – 176
2025
Q3 		$1.16M Buy
16,590
+1,767
+12% +$132K 0.29% 72
2025
Q2 		$1.05M Buy
14,823
+2,575
+21% +$155K 0.3% 69
2025
Q1 		$778K Sell
12,248
-1,457
-11% -$107K 0.25% 80
2024
Q4 		$1.04M Buy
13,705
+3,153
+30% +$248K 0.3% 70
2024
Q3 		$933K Buy
10,552
+1,771
+20% +$139K 0.31% 68
2024
Q2 		$676K Buy
8,781
+643
+8% +$59.8K 0.24% 82
2024
Q1 		$765K Buy
8,138
+996
+14% +$101K 0.29% 77
2023
Q4 		$775K Buy
+7,142
New +$767K 0.32% 72

Other funds holding NKE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prostatis Group's NKE Position: Q4 2025 in Review

Prostatis Group sold out of Nike (NKE) in Q4 2025, closing a stake of 16,590 shares — an estimated $1.16M sold.

Prostatis Group first reported a position in NKE in Q4 2023 and held it in 8 quarters. The position peaked at $1.16M in Q3 2025. 2,065 funds tracked by Wall St. Rank hold NKE as of Q4 2025.

  • Prostatis Group reported no remaining Nike position as of Q4 2025 after selling out during the quarter.
  • Prostatis Group sold 16,590 Nike shares in Q4 2025, an estimated $1.16M.
  • Prostatis Group first reported a position in Nike in Q4 2023 and held it in 8 quarters.
  • Prostatis Group's Nike position peaked at $1.16M in Q3 2025.
  • 2,065 funds tracked by Wall St. Rank held Nike as of Q4 2025.

Based on Prostatis Group's 13F filing for Q4 2025, filed 17 Feb 2026.